We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
$50 for your first 3 months Get the print edition and steer from crisis to recovery
Add this topic to your myFT Digest for news straight to your inbox
Record payouts suggest the sprite engages in some complex asset-liability modelling
Documentary investigates why the pandemic disproportionately affects Bame communities
Approach seeks to cut years off traditional licensing process for treatments
Imposing a winter lockdown earlier and prioritising care home vaccinations have kept death rate lower
A tide of misinformation and centuries of medical malpractice have led to wariness around the Covid-19 jab
In this joint commission from The Lancet and Financial Times on Governing Health Futures 2030, we explore how AI and other digital advancements are being harnessed to improve healthcare in the world’s poorest regions
Research is needed to better evaluate costly technology that may offer little value
UK hopefuls cross the pond, while lockdown leaves Smith & Nephew bruised
Rio de Janeiro and several other cities to suspend some jabs because of shortages
Luxembourg-based CVC takes stakes in companies behind Britain’s inoculation programme
Distrust has its roots in ‘scientific’ experiments that aimed to prove racial superiority
Bureaucracy in the UK health system has boomed under the cover of market-driven policies
A brother’s death showed it’s never too soon to have end-of-life conversations
Move away from competition welcomed but concerns raised over ministers giving themselves more power
Tocilizumab cuts mortality risk by 15%, reduces need for ventilation and shortens time in hospital
A crisis of morale threatens to endure beyond any retreat of the virus as the pandemic enters its second year
Move comes as hundreds of homes struggle with financial burdens of coping with Covid crisis
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them even for viral infections, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
International Edition
